We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Johnson & Johnson, Intel, Procter & Gamble, Caterpillar and Halliburton
Read MoreHide Full Article
For Immediate Release
Chicago, IL – March 29, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Johnson & Johnson (JNJ - Free Report) , Intel (INTC - Free Report) , Procter & Gamble (PG - Free Report) , Caterpillar (CAT - Free Report) and Halliburton (HAL - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Research Reports for Johnson & Johnson, Intel and Procter & Gamble
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson, Intel and Procter & Gamble. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Buy-rated Johnson & Johnson’s shares have lost -2.2% in the last six months, outperforming the -5.4% decline of the Zacks Large Cap Pharmaceuticals industry. J&J’s sales growth accelerated in the second half of 2017 backed by higher sales in the Pharmaceutical segment and improving performance in Medical Devices.
Though quite a few key products in J&J’s portfolio like Remicade and Concerta are facing generic competition, the Zacks analyst thinks new products in all segments, label expansion of drugs like Imbruvica and Darzalex and contribution from recent acquisitions – mainly Actelion – can support top-line growth.
Meanwhile, share buybacks and the restructuring initiative should provide bottom-line support. J&J is also making rapid progress with its pipeline and line extensions. However, headwinds like generics, pricing pressure and soft global market conditions remain.
Shares of Intel’s shares have outperformed the Zacks General Semiconductor industry over the past six months, gaining +34.4% vs. +27.2%. Intel is the world’s largest manufacturer of semiconductor products. The company is benefiting from robust performance of the DCG, IoT Group, NSG and PSG. These segments form the crux of Intel’s data-centric business model.
Further, the launch of FPGA SDK for OpenCL solution, Xeon Scalable, Core 8 chips, Myriad X and next-generation desktop processors are key catalysts. Lately, Intel’s Movidius vision processing has gained strong adoption. The processor was selected by Alphabet’s Google division and Amazon.com’s DeepLens.
Intel's partnerships with BMW, Nissan, Volkswagen AG and Ferrari will boost sales of processing chips, sensor-chips, cloud software and many more, which will drive top-line growth. However, stiff competition from peers adds to its woes.
Procter & Gamble's shares have underperformed the Zacks Soap and Cleaning Materials industry over the last six months (-14.5% vs. -10.6%). The Zacks analyst likes its strong brand recognition, diversified portfolio, impressive product development capabilities and marketing prowess as well as strong cash flow productivity.
The company remains focused on balanced growth through improved product, packaging, and marketing initiatives and productivity cost-savings plan. Earnings estimates for fiscal 2018 have moved north over the last 60 days signaling analysts’ optimism.
However, slowing market growth, weak volumes and organic sales have been hurting sales. Soft consumer-spending environment in developed markets and uncertainties in emerging countries also add to the worries. That said, P&G is speeding up innovations and investments to counter the softening industry growth.
Other noteworthy reports we are featuring today include Caterpillar and Halliburton.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Johnson & Johnson, Intel, Procter & Gamble, Caterpillar and Halliburton
For Immediate Release
Chicago, IL – March 29, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Johnson & Johnson (JNJ - Free Report) , Intel (INTC - Free Report) , Procter & Gamble (PG - Free Report) , Caterpillar (CAT - Free Report) and Halliburton (HAL - Free Report) .
Here are highlights from Wednesday’s Analyst Blog:
Top Research Reports for Johnson & Johnson, Intel and Procter & Gamble
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson, Intel and Procter & Gamble. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Buy-rated Johnson & Johnson’s shares have lost -2.2% in the last six months, outperforming the -5.4% decline of the Zacks Large Cap Pharmaceuticals industry. J&J’s sales growth accelerated in the second half of 2017 backed by higher sales in the Pharmaceutical segment and improving performance in Medical Devices.
Though quite a few key products in J&J’s portfolio like Remicade and Concerta are facing generic competition, the Zacks analyst thinks new products in all segments, label expansion of drugs like Imbruvica and Darzalex and contribution from recent acquisitions – mainly Actelion – can support top-line growth.
Meanwhile, share buybacks and the restructuring initiative should provide bottom-line support. J&J is also making rapid progress with its pipeline and line extensions. However, headwinds like generics, pricing pressure and soft global market conditions remain.
Shares of Intel’s shares have outperformed the Zacks General Semiconductor industry over the past six months, gaining +34.4% vs. +27.2%. Intel is the world’s largest manufacturer of semiconductor products. The company is benefiting from robust performance of the DCG, IoT Group, NSG and PSG. These segments form the crux of Intel’s data-centric business model.
Further, the launch of FPGA SDK for OpenCL solution, Xeon Scalable, Core 8 chips, Myriad X and next-generation desktop processors are key catalysts. Lately, Intel’s Movidius vision processing has gained strong adoption. The processor was selected by Alphabet’s Google division and Amazon.com’s DeepLens.
Intel's partnerships with BMW, Nissan, Volkswagen AG and Ferrari will boost sales of processing chips, sensor-chips, cloud software and many more, which will drive top-line growth. However, stiff competition from peers adds to its woes.
Procter & Gamble's shares have underperformed the Zacks Soap and Cleaning Materials industry over the last six months (-14.5% vs. -10.6%). The Zacks analyst likes its strong brand recognition, diversified portfolio, impressive product development capabilities and marketing prowess as well as strong cash flow productivity.
The company remains focused on balanced growth through improved product, packaging, and marketing initiatives and productivity cost-savings plan. Earnings estimates for fiscal 2018 have moved north over the last 60 days signaling analysts’ optimism.
However, slowing market growth, weak volumes and organic sales have been hurting sales. Soft consumer-spending environment in developed markets and uncertainties in emerging countries also add to the worries. That said, P&G is speeding up innovations and investments to counter the softening industry growth.
Other noteworthy reports we are featuring today include Caterpillar and Halliburton.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.
See This Ticker Free >>
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.